DIN 02460416 — FIASP 100 UNIT
FIASP is a solution of Insulin Aspart marketed by NOVO NORDISK CANADA INC. The full Insulin Aspart monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02460416
- Brand name
- FIASP
- Active ingredient
- Insulin Aspart
- Strength
- 100 UNIT
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- NOVO NORDISK CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Rapid-acting insulin analogue (antidiabetic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Insulin Aspart products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02460408 | FIASP | 100 UNIT | SOLUTION | NOVO NORDISK CANADA INC | MARKETED |
| 02460424 | FIASP | 100 UNIT | SOLUTION | NOVO NORDISK CANADA INC | DORMANT |
| 02520974 | KIRSTY | 100 UNIT | SOLUTION | BIOCON BIOLOGICS CANADA INC | MARKETED |
| 02244353 | NOVORAPID | 100 UNIT | SOLUTION | NOVO NORDISK CANADA INC | MARKETED |
| 02245397 | NOVORAPID | 100 UNIT | SOLUTION | NOVO NORDISK CANADA INC | MARKETED |
| 02506564 | TRURAPI | 100 UNIT | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED |
| 02506572 | TRURAPI | 100 UNIT | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED |
| 02529254 | TRURAPI | 100 UNIT | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED |